ACTU – actuate therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Actuate Announces Scientific Reports Publication on Elraglusib’s Novel Immunomodulatory Mechanism of Action as a GSK-3ß Inhibitor
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma
Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Form 10-Q ACTUATE THERAPEUTICS, For: Jun 30
Form SEC STAFF LETTER ACTUATE THERAPEUTICS,
Form SEC STAFF LETTER ACTUATE THERAPEUTICS,
Form 4/A ACTUATE THERAPEUTICS, For: Aug 12 Filed by: BP Directors, LP
Form 4/A ACTUATE THERAPEUTICS, For: Aug 12 Filed by: BIOS Fund II NT, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.